Improving the quality of life in Arizona to benefit future generations.
Building Arizona as a global center for research and commercialization in the biosciences.
Connect with Flinn Bioscience: Stay up to date. Join our email list.
The Flinn Foundation supports the biosciences in Arizona through research and entrepreneurship grants as well as stewardship of Arizona’s Bioscience Roadmap, guiding the growth and development of the state’s bioscience sector since 2002. The third iteration of the Roadmap was released in September 2025.
The biosciences improve our world by developing treatments for health afflictions with safer and more affordable medicines, creating diagnostics that gauge and prevent illness, and strengthening our food supply. In addition, the biosciences strengthen and diversify our economy by creating cutting-edge companies and high-paying jobs.
The Roadmap’s vision is for Arizona to be a nationally recognized, rising bioscience leader with a skilled talent base, world-class research, and dynamic industry growth, exemplifying collaboration, agility, and the courage to bet on discoveries that strengthen the economy and Arizonans’ health and quality of life.
An internationally recognized University of Arizona researcher and executive and a Phoenix Bioscience Core developer with Wexford Science and Technology have been named chair and vice chair of the Arizona’s Bioscience Roadmap Steering Committee.
Jennifer Barton, Ph.D., and Kyle Jardine will serve two-year terms in their roles heading up the 100-strong statewide leadership group, administered by the Flinn Foundation, which oversees the Roadmap and advocates for the state’s growing bioscience ecosystem. Their passion and expertise will play a major role in advancing the goals of the new Roadmap, including Arizona becoming a nationally recognized bioscience leader by 2030. [Read more]
The 2026 Flinn Foundation Bio Capital Conference: What Investors Want; What Entrepreneurs Need, returns Thursday, March 5 to the Creighton University Health Sciences Campus at Park Central in Phoenix. Join bioscience founders, investors, ecosystem partners, and service providers for a high-energy day of networking and learning.
Registration is open. The cost is $80. The event is presented by the Flinn Foundation, in collaboration with the Risk Capital Project Team of Arizona’s Bioscience Roadmap Steering Committee, and generously sponsored by J.P. Morgan, Procopio, Phoenix Bioscience Core, CLA, Alliant, and BIOSA. [Register]
Arizona has joined 10 regions across the U.S. as part of a new network exploring how the arts can be used to improve the health and well-being of individuals and communities. Neuroarts is an emerging field that explores how arts and aesthetic experiences change the brain, body, and behavior and how this knowledge can be applied as health care.
The Community Neuroarts Coalitions Network is a key building block of the NeuroArts Blueprint Initiative, which is helmed by Johns Hopkins University School of Medicine’s International Arts + Mind Lab Center for Applied Neuroaesthetics and the Aspen Institute’s Health, Medicine & Society Program. [Read more]
Dr. Eric Reiman, who has led Arizona’s transformation into a destination for Alzheimer’s and other age-related research, received the 2025 AZBio Pioneer Award for Lifetime Achievement at the annual AZBio Awards in October.
A world-renowned researcher and collaborator dedicated to patient care, Reiman is the CEO of Banner Alzheimer’s Institutes, director of the Arizona Alzheimer’s Consortium, an Arizona State University and University of Arizona professor, a clinical director at Translational Genomics Research Institute, or TGen, and a leader of the Alzheimer’s Prevention Initiative. Yet, as he says in this Q&A, Reiman remains intently focused on his work ahead. [Read more]
A new blueprint for Arizona’s emerging bioscience ecosystem lays out a plan for the state to capitalize on more than two decades of momentum and become a nationally recognized leader.
Bioscience focuses on the research, development, and commercialization of therapies and products to prevent, diagnose, and treat disease, improve health outcomes, enhance crops, and generate biological solutions for environmental and industrial challenges. It strengthens and diversifies our economy by creating cutting-edge companies and high-paying jobs.
The Roadmap was launched at events in Flagstaff, Tucson, and Phoenix with bioscience and community leaders whose vision and innovation are leading Arizona to new heights in the biosciences. [Read more]
Bioscience
An internationally recognized University of Arizona researcher and executive and a Phoenix Bioscience Core developer with Wexford Science and Technology have been named chair and vice chair of the Arizona’s Bioscience Roadmap Steering Committee. Jennifer Barton, Ph.D., and Kyle Jardine will serve two-year terms in their roles heading up the statewide leadership group, administered by […]
Bioscience
*This article first appeared in the Winter 2025 issue of Arizona Physician magazine, a publication of the Maricopa County Medical Society. By Brian PowellFlinn Foundation The Arizona Cardinals and the state’s ascension in the biosciences over the past two decades are forever linked. The football team had received voter approval for a new retractable-roof stadium, […]
Bioscience
U of A and partner to open medical school branch in Yuma / Arizona Daily Star
The University of Arizona College of Medicine-Phoenix will open a medical school branch in Yuma, partnering with Onvida Health, to help address a severe shortage of rural doctors. A three-year primary care accelerated pathway program will be offered starting in 2026.
Bioscience
State arts commission, philanthropies join national network of neuroarts advocates / Flinn Foundation
Arizona has joined 10 regions across the U.S. as part of the new Community Neuroarts Coalitions Network to explore how the arts can be used to improve the health and well-being of individuals and communities.